Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GingerBread Capital is an active, mission-driven venture capital firm founded by Linnea Roberts in 2016. It invests in female-led, technology-enabled companies, with a notable focus on healthcare, life sciences, wellness, and related sectors. The portfolio spans digital health, fertility, elder care, mental health, and more, often backing companies at early and growth stages. Notable investment outcomes in its portfolio include later-stage, unicorn-status companies such as Maven Clinic ($1B, telemedicine for women's/family health), Spring Health ($2B, mental health), Workit Health (addiction recovery, $118M Series C), Tia ($100M Series B, women's health). GingerBread Capital is not a biotech or healthcare developer but supports multiple companies that are, especially in life sciences and healthcare.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GingerBread Capital.